Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIB squamous cell carcinoma of the uterine cervix treated with radiation therapy alone

Gynecologic Oncology

Volumn 63, Issue 2, 1996, Pages 216-218

  Ebara, Takeshi ^a   Mitsuhashi, Norio ^a   Saito, Yoshihiro ^a   Sakurai, Hideyuki ^a   Hasegawa, Masatoshi ^a   Takahashi, Mitsuhiro ^a   Takahashi, Takeo ^a   Hayakawa, Kazushige ^a   Niibe, Hideo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0030298333     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0309     Document Type: Article

References (20)

1. 1. Levin, A. J., Momand, J., and Finlay, A. The p53 tumor suppressor gene, Nature 351, 453-456 (1991).
2. 2. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers, Science 253, 49-53 (1991).
3. 3. Scott, N., Sagar, P., Stewart, J., Blair, G. E., Dixon, M. F., and Quirke, P. p53 in colorectal cancer: Clinicopathological correlation and prognostic significance, Br. J. Cancer 63, 317-319 (1991).
4. 4. Gabbert, H. E., Müller, W., Schneiders, A., Meier, S., and Hommel, G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma, Cancer 76, 720-726 (1995).
5. 5. Martin, H. M., Filipe, M. I., Morris, R. W., Lane, D. P., and Silvestre, F. p53 expression and prognosis in gastric carcinoma, Int. J. Cancer 50, 859-862 (1992).
6. 6. Wang, D. Y., Xing, Y. Y., Tanaka, M., Li, X. R., Li, J. L., Shen, Q., Sugimura, H., and Kino, I. High prevalence of p53 protein overexpression in patients with esopageal cancer in Linxian, China and its relationship to progression and prognosis, Cancer 74, 3089-3096 (1994).
7. 7. Gallo, O., Franchi, A., Bianchi, S., Boddi, V., Giannelli, E., and Alajmo, E. p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome, Cancer 75, 2037-2044 (1995).
8. 8. Langendijk, J. A., Thunnissen, F. B. J. M., Lamers, R. J. S., de Jong, J. M. A., ten Velde, G. P. M., and Wouters, E. F. M. The prognostic significance of accumulation of p53 protein in stage III non-small cell lung cancer treated by radiotherapy, Radiother. Oncol. 36, 218-224 (1995).
9. 9. Oka, K., Nakano, T., and Arai, T. p53CM1 expression is not associated with prognosis in uterine cervical carcinoma, Cancer 72, 160-164 (1993).
10. 10. Gitsch, G., Kainz, C., Joura, E., and Breitenecker, G. Mutant p53 product in patients with stage III cervical cancer, Anticancer Res. 12, 2241-2242 (1992).
11. 11. Kainz, C., Kohlberger, P., Gitsch, G., Sliutz, G., Breitenecker, G., and Reinthaller, A. Mutant p53 in patients with invasive cervical cancer stages IB to IIB, Gynecol. Oncol. 57, 212-214 (1995).
12. 12. Mitsuhashi, N., Takahashi, M., Nozaki, M., Yamakawa, M., Takahashi, T., Sakurai, H., Hayakawa, K., and Niibe, H. Evaluation of external beam therapy and three brachytherapy fractions for carcinoma of the uterine cervix, Int. J. Radiat. Oncol. Biol. Phys. 29, 975-982 (1994).
13. 13. Holm, R., Skomedal, H., Helland, P., Borresen, A., and Nesland, J. M. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri, J. Pathol. 169, 21-26 (1993).
14. 14. Werness, B. A., Levine, A. J., and Howley, P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53, Science 248, 76-79 (1990).
15. 15. Park, T. W., Fujiwara, H., and Wright, T. C. Molecular biology of cervical cancer and its precursors, Cancer 76, 1902-1913 (1995).
16. 16. Busby-Earle, R. M. C., Steel, C. M., and Bird, C. C. Cervical carcinoma: Low frequency of allele loss at loci implicated in other common malignancies, Br. J. Cancer 67, 71-75 (1993).
17. 17. Fujita, M., Inoue, M., Tanizaki, O., Iwamoto, S., and Enomoto, T. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection, Cancer Res. 52, 5323-5328 (1992).
18. 18. Tsuda, H., and Hirohashi, S. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes, Jpn. J. Cancer Res. 83, 1184-1191 (1992).
19. 19. Yokota, J., Tsukada, Y., Nakajima, T., Gotoh, M., Shimosato, Y., Mori, N., Tsunokawa, Y., Sugimura, T., and Terada, M. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix, Cancer Res. 49, 3598-3601 (1989).
20. 20. Mitsuhashi, N., Takahashi, M., Nozaki, M., Yamakawa, M., Takahashi, T., Sakurai, H., Maebayashi, K., Hayakawa, K., and Niibe, H. Squamous cell carcinoma of the uterine cervix: Radiation therapy for patients aged 70 years and older, Radiology 194, 141-145 (1994).